| 查看: 276 | 回复: 0 | |||
村口一蹲木虫 (著名写手)
无
|
[交流]
【求助】求助哈，帮帮忙，求全文
|
|
1、Diabetes Care. 2009 Jul;32(7):1237-43. Epub 2009 Apr 14. Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study. 2、Horm Metab Res. 2009 Dec;41(12):905-9. Epub 2009 Aug 24. Efficacy and safety comparison between the DPP-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-naïve patients with type 2 diabetes. 3、Horm Metab Res. 2009 May;41(5):368-73. Epub 2009 Feb 16. Efficacy and tolerability of vildagliptin in patients with type 2 diabetes inadequately controlled with metformin monotherapy 4、Horm Metab Res. 2008 Dec;40(12):892-5. Epub 2008 Aug 22. Efficacy and safety of vildagliptin monotherapy during 2-year treatment of drug-naïve patients with type 2 diabetes: comparison with metformin. 5、Horm Metab Res. 2007 Mar;39(3):218-23. Vildagliptin in drug-naïve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose study. 6、Horm Metab Res. 2006 Jun;38(6):423-8. Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes. 7、Diabetes Care. 2005 Aug;28(8):1936-40. Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. 8、Horm Metab Res. 2008 Jun;40(6):427-30. Epub 2008 Mar 11.（已经找到全文） Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus. |
回复此楼» 猜你喜欢
估计是周四
已经有3人回复
-
基金啊基金
已经有3人回复
-
科研孤儿太难了
已经有15人回复
-
让我中一个面上吧！
已经有10人回复
-
言之凿凿，明天官网会通知放榜？
已经有17人回复
-
时间戳又变了
已经有17人回复
-
今天系统多次维护，明天很可能放榜！
已经有11人回复
-
时间戳变了，能看出什么问题？
已经有23人回复
-
只有每年这种时候来逛逛小木虫
已经有22人回复
-
放榜前的不淡定
已经有12人回复
